[New aspects of the use of spironolactone and its association with thiabutazide (per os and in injections) in the treatment of grave cardiac insufficiency].
D058186:Acute Kidney Injury / Q000188:drug therapy; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001581:Benzothiadiazines; D048909:Diabetes Complications; D004232:Diuretics; D004487:Edema / Q000188:drug therapy; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D007267:Injections; D008297:Male; D008875:Middle Aged; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D013148:Spironolactone / Q000008:administration & dosage* / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone
Noi aspecte ale utilizării spironolactonei şi asociaţiei cu thiabutazidul (per os şi pro injectione) în tratamentul insuficienţei cardiace grave.